Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...

Only a few months ago, Illumina of San Diego announced the creation of a new bovine single-nucleotide polymorphism (SNP) chip with ten times the coverage of an earlier version. The chip's ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

The top performers in the Nasdaq 100, which was up 0.9%, were almost exclusively chip stocks, aside from the third-best performer: Illumina. Micron Technology, Broadcom, Lam Research, Applied ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest and most diverse database of genetic information in the ...